Treace Medical Concepts Share Price (NASDAQ: TMCI)

$7.34

▲

-0.06

(-0.81%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Treace Medical Concepts Stock chart to analyse performance

Treace Medical Concepts stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$7.30
Today's High:$7.52
$7.34
0.54%
Downside
Day's Volatility :2.93%
Upside
2.39%
52 Weeks Low:$4.54
52 Weeks High:$10.79
$7.34
38.15%
Downside
52 Weeks Volatility :57.92%
Upside
31.97%

Treace Medical Concepts Stock Returns

Period	Treace Medical Concepts Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	27.7%	3.6%	0.0%
6 Months	-16.32%	-7.7%	0.0%
1 Year	28.15%	-12.6%	0.0%
3 Years	-62.83%	9.5%	-4.7%

Treace Medical Concepts Inc Key Stats

Check Treace Medical Concepts key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$7.4
Open	$7.52
Today's High	$7.52
Today's Low	$7.3
Market Capitalization	$468.7M
Today's Volume	$205.5K
52 Week High	$10.79
52 Week Low	$4.54
Revenue TTM	$213.8M
EBITDA	$-39.4M
Earnings Per Share (EPS)	$-0.79
Profit Margin	-23.01%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-46.89%

Stock Returns calculator for Treace Medical Concepts Stock including INR - Dollar returns

The Treace Medical Concepts stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Treace Medical Concepts investment value today

Current value as on today

₹1,24,247

Returns

₹24,247

(+24.25%)

Returns from Treace Medical Concepts Stock

₹18,963 (+18.96%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Treace Medical Concepts Stock

-38%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Treace Medical Concepts Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Treace Medical Concepts Inc

Name
Holdings %
Name
Holdings %
Armistice Capital, LLC
9.91%
BlackRock Inc
6.15%
William Blair Investment Management, LLC
4.91%
Vanguard Group Inc
4.31%
Gagnon Securities LLC
3.56%
JPMorgan Chase & Co
2.93%

Analyst Recommendation on Treace Medical Concepts Stock

Rating

Trend

Buy

84%Buy

15%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Treace Medical Concepts(by analysts ranked 0 to 5 stars)

Treace Medical Concepts Share Price Target

What analysts predicted

Upside of 13.76%

Target:

$8.35

Current:

$7.34

Treace Medical Concepts share price target is $8.35, a slight Upside of 13.76% compared to current price of $7.34 as per analysts' prediction.

Treace Medical Concepts Stock Insights

Price Movement
In the last 1 month, TMCI stock has moved up by 32.3%
Decreasing Revenue
Revenue is down for the last 3 quarters, 68.70M → 47.38M (in $), with an average decrease of 16.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -501.0K → -17.39M (in $), with an average decrease of 1543.7% per quarter
TMCI vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 10.2%
TMCI vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 225.8%
Price to Sales
ForTMCI every $1 of sales, investors are willing to pay $2.1, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Treace Medical Concepts Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$39.4M	-
Net Income	$-4.3M	-
Net Profit Margin	-10.82%	-

	FY20	Y/Y Change
Revenue	$57.4M	↑ 45.54%
Net Income	$-3.7M	↓ 14.0%
Net Profit Margin	-6.39%	↑ 4.43%

	FY21	Y/Y Change
Revenue	$94.4M	↑ 64.59%
Net Income	$-20.6M	↑ 460.31%
Net Profit Margin	-21.77%	↓ 15.38%

	FY22	Y/Y Change
Revenue	$141.8M	↑ 50.22%
Net Income	$-42.8M	↑ 108.33%
Net Profit Margin	-30.19%	↓ 8.42%

	FY23	Y/Y Change
Revenue	$187.1M	↑ 31.92%
Net Income	$-49.5M	↑ 15.68%
Net Profit Margin	-26.47%	↑ 3.72%

	FY24	Y/Y Change
Revenue	$209.4M	↑ 11.89%
Net Income	$-55.7M	↑ 12.55%
Net Profit Margin	-26.63%	↓ 0.16%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$51.1M	↓ 17.85%
Net Income	$-18.7M	↑ 197.34%
Net Profit Margin	-36.54%	↓ 26.44%

	Q2 FY24	Q/Q Change
Revenue	$44.5M	↓ 13.02%
Net Income	$-21.2M	↑ 13.55%
Net Profit Margin	-47.7%	↓ 11.16%

	Q3 FY24	Q/Q Change
Revenue	$45.1M	↑ 1.42%
Net Income	$-15.4M	↓ 27.57%
Net Profit Margin	-34.07%	↑ 13.63%

	Q4 FY24	Q/Q Change
Revenue	$68.7M	↑ 52.39%
Net Income	$-501.0K	↓ 96.74%
Net Profit Margin	-0.73%	↑ 33.34%

	Q1 FY25	Q/Q Change
Revenue	$52.6M	↓ 23.49%
Net Income	$-15.9M	↑ 3078.04%
Net Profit Margin	-30.29%	↓ 29.56%

	Q2 FY25	Q/Q Change
Revenue	$47.4M	↓ 9.86%
Net Income	$-17.4M	↑ 9.27%
Net Profit Margin	-36.71%	↓ 6.42%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$31.8M	-

	FY20	Y/Y Change
Profit	$44.9M	↑ 41.25%

	FY21	Y/Y Change
Profit	$76.6M	↑ 70.6%

	FY22	Y/Y Change
Profit	$114.3M	↑ 49.25%

	FY23	Y/Y Change
Profit	$151.9M	↑ 32.91%

	FY24	Y/Y Change
Profit	$168.3M	↑ 10.75%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$41.0M	↓ 19.24%

	Q2 FY24	Q/Q Change
Profit	$35.7M	↓ 12.95%

	Q3 FY24	Q/Q Change
Profit	$36.1M	↑ 1.28%

	Q4 FY24	Q/Q Change
Profit	$55.5M	↑ 53.54%

	Q1 FY25	Q/Q Change
Profit	$41.9M	↓ 24.49%

	Q2 FY25	Q/Q Change
Profit	$37.8M	↓ 9.88%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-7.7M	-
Investing Cash Flow	$-1.2M	-
Financing Cash Flow	$19.7M	-

	FY20	Y/Y Change
Operating Cash Flow	$-4.5M	↓ 41.43%
Investing Cash Flow	$-1.1M	↓ 11.73%
Financing Cash Flow	$11.5M	↓ 41.72%

	FY21	Y/Y Change
Operating Cash Flow	$-17.2M	↑ 282.58%
Investing Cash Flow	$-2.7M	↑ 153.04%
Financing Cash Flow	$107.7M	↑ 835.86%

	FY22	Y/Y Change
Operating Cash Flow	$-30.6M	↑ 78.26%
Investing Cash Flow	$-76.5M	↑ 2728.76%
Financing Cash Flow	$20.8M	↓ 80.67%

	FY23	Y/Y Change
Operating Cash Flow	$-34.6M	↑ 12.81%
Investing Cash Flow	$-81.3M	↑ 6.25%
Financing Cash Flow	$109.4M	↑ 425.73%

	FY24	Y/Y Change
Operating Cash Flow	$-37.2M	↑ 7.5%
Investing Cash Flow	$35.4M	↓ 143.51%
Financing Cash Flow	$160.0K	↓ 99.85%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-7.2M	↓ 1457.33%
Investing Cash Flow	$3.8M	↓ 24.95%
Financing Cash Flow	$-185.0K	↓ 212.12%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-13.9M	↑ 92.45%
Investing Cash Flow	$22.4M	↑ 496.94%
Financing Cash Flow	$311.0K	↓ 268.11%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-11.8M	↓ 14.79%
Investing Cash Flow	$5.8M	↓ 74.31%
Financing Cash Flow	$8.0K	↓ 97.43%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-4.2M	↓ 64.47%
Investing Cash Flow	$3.4M	↓ 40.64%
Financing Cash Flow	$26.0K	↑ 225.0%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$4.2M	↓ 199.79%
Investing Cash Flow	$-1.9M	↓ 155.36%
Financing Cash Flow	$-282.0K	↓ 1184.62%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-3.1M	↓ 172.65%
Investing Cash Flow	$-3.3M	↑ 71.96%
Financing Cash Flow	$987.0K	↓ 450.0%

Treace Medical Concepts Technicals Summary

Sell

Neutral

Buy

Treace Medical Concepts is currently in a neutral trading position according to technical analysis indicators.

Treace Medical Concepts Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Treace Medical Concepts Inc	37.27%	-16.32%	28.15%	-62.83%	-71.29%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Treace Medical Concepts Inc	NA	NA	NA	-0.79	-0.47	-0.14	NA	1.55
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Treace Medical Concepts Inc	Buy	$468.7M	-71.29%	NA	-23.01%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Organization	Treace Medical Concepts
Employees	477
CEO	Mr. John T. Treace
Industry	Healthcare

Key Management of Treace Medical Concepts Inc

Name	Title
Mr. John T. Treace	Founder, Chairman & CEO
Mr. Mark L. Hair CPA	Chief Financial Officer
Mr. Scot M. Elder J.D.	Chief Legal & Compliance Officer and Corporate Secretary
Dr. Sean F. Scanlan Ph.D.	Chief Innovation Officer
Mr. Gaetano M. Guglielmino	Chief Commercial Officer
Mr. Terry W. Lubben	Chief Operations & Supply Chain Officer
Mr. Taylor Erickson	Chief Information & Cybersecurity Officer
Mr. Brad Barr	Senior Vice President of Sales
Mr. Daniel E. Owens	Chief Human Resources Officer
Ms. Shana Zink	Senior Vice President of Clinical Affairs & Reimbursement

Important FAQs about investing in TMCI Stock from India :

What is Treace Medical Concepts share price today?

Treace Medical Concepts share price today is $7.34 as on August 30, 2025 at 1:29 am IST at the close of the market. Treace Medical Concepts share today touched a day high of $7.52 and a low of $7.30.

What is the 52 week high and 52 week low for Treace Medical Concepts share?

Treace Medical Concepts share touched a 52 week high of $10.79 and a 52 week low of $4.54. Treace Medical Concepts stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $7.34, lower by 31.97% versus the 52 week high.

How to invest in Treace Medical Concepts Stock (TMCI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Treace Medical Concepts on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Treace Medical Concepts Shares that will get you 0.2044 shares as per Treace Medical Concepts share price of $7.34 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Treace Medical Concepts Stock (TMCI) from India?

Indian investors can start investing in Treace Medical Concepts (TMCI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Treace Medical Concepts stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Treace Medical Concepts share’s latest price of $7.34 as on August 30, 2025 at 1:29 am IST, you will get 1.3624 shares of Treace Medical Concepts. Learn more about fractional shares .

What are the returns that Treace Medical Concepts has given to Indian investors in the last 5 years?

Treace Medical Concepts stock has given -71.29% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?